Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gain Therapeutics (GANX) Current Taxes (2020 - 2025)

Gain Therapeutics (GANX) has 6 years of Current Taxes data on record, last reported at $46289.0 in Q3 2025.

  • For Q3 2025, Current Taxes rose 120.41% year-over-year to $46289.0; the TTM value through Sep 2025 reached $46289.0, up 120.41%, while the annual FY2024 figure was $18493.0, 62.23% down from the prior year.
  • Current Taxes reached $46289.0 in Q3 2025 per GANX's latest filing, up from $25169.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $184693.0 in Q2 2023 and bottomed at $380.0 in Q4 2021.
  • Average Current Taxes over 5 years is $43763.7, with a median of $21001.0 recorded in 2024.
  • Peak YoY movement for Current Taxes: soared 28139.74% in 2022, then crashed 75.93% in 2025.
  • A 5-year view of Current Taxes shows it stood at $380.0 in 2021, then skyrocketed by 28139.74% to $107311.0 in 2022, then plummeted by 54.37% to $48965.0 in 2023, then crashed by 62.23% to $18493.0 in 2024, then soared by 150.31% to $46289.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Current Taxes were $46289.0 in Q3 2025, $25169.0 in Q2 2025, and $17973.0 in Q1 2025.